Home > News > Analyzing nanoparticle levels in blood
May 22nd, 2007
Analyzing nanoparticle levels in blood
Abstract:
With the race to develop nanoparticle-based therapeutics and imaging agents for cancer applications moving at full speed, a small but growing group of researchers is quietly developing the methods that are needed to fully characterize a wide variety of nanoscale materials and then detect and quantify their presence in blood and other human tissues. One such effort, headed by King Chan, Ph.D., of the National Cancer Institute, and Anil Patri, Ph.D., of the Nanotechnology Characterization Laboratory, has now developed a straightforward method for analyzing two types of fullerene nanoparticle.
Source:
nanowerk.com
Related News Press |
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Safety-Nanoparticles/Risk management
Onion-like nanoparticles found in aircraft exhaust May 14th, 2025
Closing the gaps — MXene-coating filters can enhance performance and reusability February 28th, 2025
![]() |
||
![]() |
||
The latest news from around the world, FREE | ||
![]() |
![]() |
||
Premium Products | ||
![]() |
||
Only the news you want to read!
Learn More |
||
![]() |
||
Full-service, expert consulting
Learn More |
||
![]() |